West Roxbury, MA, United States of America

Shuzhen Qin

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 11.8

ph-index = 9

Forward Citations = 263(Granted Patents)


Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Shuzhen Qin in Cancer Treatment**

Introduction

Shuzhen Qin is an accomplished inventor based in West Roxbury, MA, known for her significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio of 10 patents, her work primarily focuses on developing innovative compounds that can help in the treatment of hyperproliferative disorders, including cancer.

Latest Patents

One of Qin's notable inventions involves triazole compounds that modulate Hsp90 activity. This invention relates to substituted triazole compounds and their compositions, which are crucial for inhibiting the activity of Hsp90 in patients who need such intervention. The methods developed by Qin could revolutionize how hyperproliferative disorders, such as cancer, are treated. By administering these substituted triazole compounds, healthcare professionals can potentially offer better therapeutic options for patients suffering from these conditions.

Career Highlights

Shuzhen Qin is currently employed at Synta Pharmaceuticals Corporation, where her expertise has been instrumental in driving the company’s research and development efforts. Her extensive work in pharmacological innovations has greatly advanced the understanding and treatment methodologies for various cancers.

Collaborations

Throughout her career, Qin has had the opportunity to collaborate with esteemed colleagues, including Weiwen Ying and Kevin Paul Foley. These partnerships have enhanced the efficacy of her research and have contributed to the successful development of her patented inventions.

Conclusion

Shuzhen Qin's innovative work in the realm of cancer treatment through her patented triazole compounds showcases her dedication to improving patient outcomes. With her extensive experience and collaboration with other professionals in the field, she continues to make strides in the pharmaceutical industry, paving the way for new treatment possibilities.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…